Cell cycle control of BRCA2

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4590-4594

  Vaughn, James P ^a   Cirisano, Frank D ^a   Huper, Gudrun ^a   Berchuck, Andrew ^a   Futreal, P Andrew ^a   Marks, Jeffrey R ^a   Iglehart, J Dirk ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; LOVASTATIN; NEOPLASM PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0029815438     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Miki, Y., Swensen, J , Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W , Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M , Frye, C , Hattier, T., Phelps, R , Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S , Bayer, S , Wray, C., Borgden, R., Dayananth, P , Ward, J., Tonin, P., Narod, S., Bristow, P , Norns, F., Helvering, L., Morrison, P., Roseteck, P , Lai, M., Barrett, J C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D , Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266, 66-71, 1994.
2. Easton, D. F , Ford, D., Bishop, D. T., and Breast Cancer Linkage Consortium Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J Hum Genet., 56, 265-271, 1995.
3. Wooster, R., Bignell, G., Lancaster, J , Swift, S., Seal, S., Mangion, J., Collins, N , Gregory, S , Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D , Kelsell, D., Ford, D., Tonin, P., Bishop, D. T , Spurr, N. K., Ponder, B. A. J., Eeles, R , Peto, J., Devilee, P , Cornelisse, C , Lynch, H., Narod, S., Lenoir, G., Egilsson, V , Barkadottir, R. B., Eason, D. F , Bentley, D. R., Futreal, P A., Ashworth, A., and Stratton, M. R. Identification of the breast cancer susceptibility gene BRCA2. Nature, (Lond.), 378: 789-792, 1995.
4. Phelan, C M., Lancaster, J. M., Tonin, P., Gumbs, C., Cochran, C., Carter, R., Ghadrian, P., Perret, C., Moslehi, R., Dion, F , Faucher, M., Dole, K., Karimi, S., Foulkes, W., Lounis, H., Warner, E , Gross, P , Anderson, D , Larsson, C., Narod, S. A., and Futreal, P. A. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet , 13, 120-122, 1996
5. Couch, F. J., Weber, B. L , and Breast Cancer Information Core (BIC). Mutations and polymorphisms in the familial early onset breast cancer (BRCA1) gene Human Mut., 8: 8-18, 1996
6. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S , Merajver, S., Thorlacius, S , Offit, K , Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R , Chen, Q., Davis, T , Dumont, M , Frye, C., Hattier, T., Jammulapati, S , Janecki, T., Jiang, P., Kehrer, R , Leblanc, J.-F., Mitchell, J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M , Snyder, S. C , Steele, L., Stringfellow, M , Stroup, C., Swedlund, B., Swensen, J , Teng, D , Thomas, A., Tran, T , Tran, T., Tranchant, M., Weaver-Feldhaus, J., Wong, A K. C., Shizuya, H., Eyfjord, J E., Cannon-Albright, L., Labrie, F., Skolnick, M H., Weber, B., Kamb, A., and Goldgar, D. E. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds Nat Genet, 12: 333-337, 1996.
7. Cornelis, R S , Neuhausen, S. L., Johansson, O., Arason, A., Kelsell, D , Ponder, B A. J., Tonin, P., Hamann, U , Lindblom, A , Lalle, P , Longy, M., Olah, E., Scherneck, S., Bignon, Y-J., Sobol, H , Chang-Claude, J., Larsson, C., Spurr, N., Borg, A , Barkardottir, R B , Narod, S., Devilee, P., and Breast Cancer Linkage Consortium High allele loss rates at 17q12-21 in breast and ovarian tumors from BRCA1-linked families. Genes Chromosomes & Cancer, 13: 203-210, 1995.
8. Cleton-Jansen, A. M., N., Lakhani, S. R., Weissenbach, J., Devilee, P , Cornelisse, C. J., and Stratton, M. R. Loss of heterozygosity in sporadic breast tumors at the BRCA2 locus on chromosome 13q12-q13. Br. J. Cancer, 72: 1241-1244, 1995.
9. Futreal, P A , Liu, Q., Shattuck-Eidens, D., Cochran, C. J., Harshman, K., Tavtigian, S., Bennett, L. M. Haugen-Strano, A., Swensen, J , Miki, Y., Eddington, K , McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z , Soderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J. D., Marks, J. R., Ballinger, D., Barrett, J C., Skolnick, M., Kamb, A , and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas Science (Washington DC), 266: 120-122, 1994.
10. Lancaster, J M , Wooster, R , Mangion, J., Phelan, C M., Cochran, C., Gumbs, C., Seal, S., Barfoot, R., Collins, N., Bignell, G., Patel, S., Hamoudi, R., Larsson, C., Wiseman, R , Berchuck, A., Iglehart, J. D., Marks, J. R., Ashworth, A., Stratton, M., and Futreal, P. A BRCA2 mutations in primary breast and ovarian cancers. Nat. Genet., 13: 238-240, 1996.
11. Thompson, M. E , Jensen, R A , Obermiller, P. S., Page, D. L., and Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression Nat. Genet., 9: 444-450, 1995.
12. Chen, Y., Chen, C., Riley, D. J , Allred, D. C., Chen, P , Von Hoff, D , Osborne, C. K , and Lee, W. H. Aberrant subcellular localization of BRCA1 in breast cancer. Science. (Washington DC), 270: 789-791, 1995.
13. Gudas, J. M., Nguyen, H , Li, T., and Cowan, K. H. Hormone-dependent regulation of BRCA1 in human breast cancer cells Res , 55: 4561-4565, 1995.
14. Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Xu, J., Yin, G-Y , Abel, K J., Weber, B. L., and Chodosh, L. A. The developmental pattern of BRCA1 expression implies a role in the differentiation of the breast and other tissues. Nat. Genet., 11: 17-26, 1995.
15. Vaughn, J. P., Davis, P. L., Jarboe, M. D., Huper, G , Evans, A. C., Wiseman, R W., Berchuck, A., Iglehart, J. D., Futreal, P. A., and Marks, J. R. BRCA1 expression is induced prior to DNA synthesis in both normal and tumor derived breast cells. Cell Growth Differ., 7: 711-715, 1996.
16. Band, V., Zajchowski, D , Zulesa, V , and Sager, R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc. Natl. Acad. Sci USA , 87: 463-467, 1990
17. 1 to multiple cell cycles by lovastatin. Cancer Res., 51: 3602-3609, 1991.
18. Lowe, S W., Ruley, H. E., Jacks, T., and Housman, D E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993
19. Marks, J. R., Lin, J , Hinds, P , Miller, D., and Levine, A. J. Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen J Virol., 63: 790-797, 1989.
20. Marraccino, R L. and Keng, P. C. Centrifugal elutriation. In: M Pagano (ed.), Cell cycle- Materials and Methods, pp 53-62, Berlin; Springer-Verlag. 1996.
21. Mosca, P. J., Dijkwel, P. A , and Hamlin, J Z. The plant amino acid mimosine may inhibit initiation of origins of replication in CHO cells. Mol. Cell Biol., 12: 4375-4383, 1992
22. Thorlacius, S , Tryggvadottir, L , Olafsdottir, G. H., Jonasson, J G , Ogmundsdottir, H. M , Tulinius, H., and Eyfjord, J. E. Linkage to BRCA2 region in hereditary male breast cancer. Lancet, 346 544-545, 1995.
23. Narod, S. A., Ford, D., Devilee, P., Barkardottir, R. B., Lynch, H. T., Smith, S. A., Ponder, B. A., Weber, B L., Garber, J. E., Birch, J M., Cornelis, R. S., Kelsell, D. P., Spurr, N K., Smyth, E., Haites, N., Sobol, H., Bignon, Y , Chang-Claude, J., Hamman, U , Lindblom, A., Borg, A., Piver, M. S., Gallion, H. H , Streuwing, J. P , Whittemore, A., Tonin, P., Goldgar, D E., Easton, D. F., and Breast Cancer Linkage Consortium. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J. Hum. Genet., 56: 254-264, 1995.
24. Suzuki, H., Romano-Spica, V., Papas, T. S., and Bhat, N. K ETS1 suppresses tumorigenicity of human colon cancer cells. Proc. Natl. Acad. Sci. USA., 92: 4442-4446, 1995.